BRKR - Bruker Corporation

NasdaqGS - NasdaqGS Delayed Price. Currency in USD

Bruker Corporation

40 Manning Road
Billerica, MA 01821
United States
978-663-3660
http://www.bruker.com

SectorHealthcare
IndustryDiagnostics & Research
Full Time Employees6,200

Key Executives

NameTitlePayExercisedYear Born
Dr. Frank H. LaukienChairman, CEO & Pres1.4M31.22k1960
Dr. Mark R. Munch Ph.D.Exec. VP, Pres of Bruker Nano Surfaces Division and Pres of Bruker Nano Group714.78k967.18k1962
Mr. Juergen SregaPres of Bruker Daltonics Division and Pres of Bruker CALID Group523.97kN/A1955
Mr. Anthony L. MattacchioneFormer CFO & Sr. VP773.17kN/A1963
Mr. Gerald N. HermanVP, Interim CFO and Principal Accounting Officer & Corp. ControllerN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology and diagnostics, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers, and other businesses involved in materials analysis. It markets its products through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.

Corporate Governance

Bruker Corporation’s ISS Governance QualityScore as of April 1, 2018 is 7. The pillar scores are Audit: 10; Board: 7; Shareholder Rights: 4; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.